Stocks
Corcept Therapeutics Incorporated (CORT) EV/EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 19.9 | 19.5 | 15.7 | 15.4 | 27.7 | 15.5 | ||
| Changes by years, y/y, % | +111% | -2% | -20% | -2% | +80% | +13.2% | |||
Corcept Therapeutics Incorporated. EV/EBITDA
Corcept Therapeutics Incorporated. EV/EBITDA, changes, %
Corcept Therapeutics Incorporated (CORT) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | 24.5 | 27.2 | 17.6 | 22.4 | 30.5 | 15.5 | |
| Changes by years, y/y, % | +35% | +78% | -4% | +18% | +25% | |||
| Changes by quarters, q/q, % | +29% | +11% | -35% | +27% | +36% | |||
